Recent advances in the search for new drugs for treatment of toxoplasmosis
Open Access
- 31 December 1992
- journal article
- review article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 1 (4), 153-164
- https://doi.org/10.1016/0924-8579(92)90002-9
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Clindamycin for toxoplasma encephalitis in AIDSThe Lancet, 1991
- In vivo activity of the macrolide antibiotics azithromycin, roxithromycin and spiramycin againstToxoplasma gondiiEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Safety and Pharmacokinetics of 566C80, a Hydroxynaphthoquinone with Anti-Pneumocystis carinii Activity: A Phase I Study in Human Immunodeficiency Virus (HIV)-Infected MenThe Journal of Infectious Diseases, 1991
- Role of gamma interferon inToxoplasma gondii infectionEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Activity of A-56268 (TE-031), a new macrolide, against Toxoplasma gondii in miceJournal of Antimicrobial Chemotherapy, 1988
- In Vivo Activity of Piritrexin Against Toxoplasma gondiiThe Journal of Infectious Diseases, 1987
- In vivo and in vitro activity of roxithromycin againstToxoplasma gondii in miceEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987
- Potent in Vivo Activity of Arprinocid, a Purine Analogue, Against Murine ToxoplasmosisThe Journal of Infectious Diseases, 1986
- Immune interferon: a pleiotropic lymphokine with multiple effectsImmunology Today, 1985
- Impaired Production of Lymphokines and Immune (Gamma) Interferon in the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1984